News

Opvee (Nalmefene) Will Be Released in the Fourth Quarter of 2023

 Opvee (Nalmefene) Will Be Released in the Fourth Quarter of 2023 Opvee is indicated for…

Jun 21, 2023
Release of Zavzpret In Late July 2023

Release of Zavzpret In Late July 2023 Zavzpret is indicated for the acute treatment of…

Jun 19, 2023
The Approval of Over-the-Counter Narcan Nasal Spray

The approval of over-the counter Narcan nasal spray  The U.S. Food and Drug Administration approved…

Apr 14, 2023
Generic Latuda (Lurasidone Hydrochloride) Is Now Available

The generic formulation of Latuda (Lurasidone Hydrochloride) has been approved by the FDA. Lurasidone Hydrochloride…

Mar 03, 2023
Generic Release Of Trokendi XR Is Now Available

Launch of generic Trokendi XR (Topiramate capsule, extended release)  Topiramate extended-release capsules are indicated as…

Feb 01, 2023
Generic Release Of Cambia Is Now Available

Launch of generic Cambia (diclofenac potassium powder, for oral solution) Diclofenac potassium powder for oral…

Jan 17, 2023
Generic Release Of Pradaxa

The generic formulation of Pradaxa (Dabigatran Etexilate) has been recently released. Dabigatran is used for…

Nov 01, 2022
Generic Release Of Toviaz Is Now Available

The generic formulation of Toviaz (Fesoterodine) has been recently released. Fesoterodine is used for the…

Jul 08, 2022
  • This field is for validation purposes and should be left unchanged.


Filter Articles

Discover our latest educational white paper on topical analgesics in Workers’ Compensation.

Learn how these skin-applied medications effectively relieve minor muscle and joint pain. According to the Workers Compensation Research Institute, payments for topical analgesics have surged from 9% in 2015 to 19% in 2020. This upward trend in prescriptions for pain management continues to grow annually. Explore the full report for in-depth insights. Click below for more details!

Download Now
Topical Analgesics in Workers Compensation Cases: An Overview